Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Utta Schurig"'
Autor:
L. Häckel, Utta Schurig, U. Sicker, E. Spindler-Raffel, Ingo Spreitzer, I. Bekeredjian-Ding, Jan-Oliver Karo
Publikováno v:
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 58:1225-1232
Ensuring microbiological safety in advanced-therapy medicinal products is still a big challenge for manufacturers. There are fundamental problems, especially in cell-based medicinal products, regarding sterility of source materials, short shelf-life
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::27f176ea428f271eaa6fbe03d464323b
https://doi.org/10.1007/s00103-015-2237-z
https://doi.org/10.1007/s00103-015-2237-z
Autor:
Melanie Stormer, Utta Schurig, M. Bubenzer, Ingo Spreitzer, Thomas Montag-Lessing, Bjoern Becker, U. Sicker, R. Beshir, Christian Schneider, J. Brachert, Bettina Löschner, Christina Bache
Publikováno v:
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 53:45-51
Die Sterilitat von parenteral verabreichten Arzneimitteln wird heutzutage als selbstverstandlich vorausgesetzt. In der pharmazeutischen Industrie wurden exakt definierte Verfahren etabliert, die einen effizienten Schutz vor Kontaminationen durch Bakt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b7a40c5d4c7f4cff82931d22990cdfe
https://doi.org/10.1007/s00103-009-0993-3
https://doi.org/10.1007/s00103-009-0993-3
Bacterial safety of cell-based therapeutic preparations, focusing on haematopoietic progenitor cells
Autor:
Erica M. Wood, Utta Schurig, Melanie Stormer, Ingo Spreitzer, Thomas Montag, Oliver Karo, Carl P. McDonald
Publikováno v:
Vox sanguinis. 106(4)
Bacterial safety of cellular preparations, especially haematopoietic progenitor cells (HPCs), as well as advanced therapy medicinal products (ATMPs) derived from stem cells of various origins, present a challenge for physicians, manufacturers and reg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f2bd08b68d73451ae7c9cb25791a689
https://pubmed.ncbi.nlm.nih.gov/24697216
https://pubmed.ncbi.nlm.nih.gov/24697216
Autor:
Utta Schurig, Helga Huber, Margarete Heiden, Egbert Flory, Thomas Montag, Michael Schwanig, Ralf Sanzenbacher, Sven-Boris Nicol, Christian Schneider
Publikováno v:
Clinical Chemistry and Laboratory Medicine. 46
Today, sterility of established parenteral drugs including biologicals, such as plasma derived products, is practically guaranteed. Bacterially contaminated products are extremely rare exceptions owing to the efficiency of the manufacturing processes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81264862570442ac349bfaebe39bf5c5
https://doi.org/10.1515/cclm.2008.175
https://doi.org/10.1515/cclm.2008.175